1-15807479-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001089591.2(UQCRHL):āc.171A>Gā(p.Val57=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00696 in 1,614,144 control chromosomes in the GnomAD database, including 124 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0064 ( 8 hom., cov: 32)
Exomes š: 0.0070 ( 116 hom. )
Consequence
UQCRHL
NM_001089591.2 synonymous
NM_001089591.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.316
Genes affected
UQCRHL (HGNC:51714): (ubiquinol-cytochrome c reductase hinge protein like) This gene has characteristics of a pseudogene derived from the UQCRH gene. However, there is still an open reading frame that could produce a protein of the same or nearly the same size as that of the UQCRH gene, so this gene is being called protein-coding for now. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 1-15807479-T-C is Benign according to our data. Variant chr1-15807479-T-C is described in ClinVar as [Benign]. Clinvar id is 786846.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.316 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00702 (10264/1461886) while in subpopulation MID AF= 0.0472 (272/5768). AF 95% confidence interval is 0.0426. There are 116 homozygotes in gnomad4_exome. There are 5562 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UQCRHL | NM_001089591.2 | c.171A>G | p.Val57= | synonymous_variant | 1/1 | ENST00000696689.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UQCRHL | ENST00000696689.1 | c.171A>G | p.Val57= | synonymous_variant | 1/1 | NM_001089591.2 | P1 | ||
UQCRHL | ENST00000483273.2 | c.171A>G | p.Val57= | synonymous_variant | 1/1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00637 AC: 969AN: 152140Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
969
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00934 AC: 2348AN: 251490Hom.: 28 AF XY: 0.0105 AC XY: 1427AN XY: 135918
GnomAD3 exomes
AF:
AC:
2348
AN:
251490
Hom.:
AF XY:
AC XY:
1427
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00702 AC: 10264AN: 1461886Hom.: 116 Cov.: 32 AF XY: 0.00765 AC XY: 5562AN XY: 727242
GnomAD4 exome
AF:
AC:
10264
AN:
1461886
Hom.:
Cov.:
32
AF XY:
AC XY:
5562
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00638 AC: 971AN: 152258Hom.: 8 Cov.: 32 AF XY: 0.00725 AC XY: 540AN XY: 74442
GnomAD4 genome
AF:
AC:
971
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
540
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at